RheumNow Week in Review – RheumNow Live Meeting Announcement (9.21.18) Save

Dr. Jack Cush reviews the news and updates from the past week on RheumNow.

1. Beth L. Jonas, MD, Is Named Chief of Rheumatology, Allergy and Immunology at the Univ of N. Carolina School of Medicine. https://t.co/zAUQlTSspV
2. Limited sample of 35 pregnancies (in 25 pts w/ psoriatic arthritis) shows most do well thru-out preg & 1/2 flare post partum. Of the 2/3 on biologics - discontinuation was assoc w/ flares & pred use. Biologic continuation showed no change in Dz activity https://t.co/xzZHGU4vRp
3. Chronic back pain suspected of having axial spondyloarthritis (axSpA) should not undergo follow-up MRI of the sacroiliac joint (MRI-SI) within a year if they had a previously negative baseline MRI-SI https://t.co/OoXDzcBTNd
4. MMWR/NHIS shows in 2016 20.4% of US adults had chronic pain, 8% had high-impact (limiting) pain; Both more prevalent w/ poverty, less education, & public health insurance. Pain costs US $560 billion/YR in direct med costs, lost productivity, & disability https://t.co/EBhqOWZ6mP
5. Galectin-9: an easy measure of IFN signature in SLE, Galectin-9, CXCL-10 & TNF-RII measured SLE, SLE+APS, primary APS; All correlated with Dz activity and Galectin-9 was better than dsDNA, CXCL-10 or TNF-RII in correlating w/ IFN score (r=0.70, p<0.001). https://t.co/yMsHIJxhQN
6. Dermatology (EADV) Congress in Paris reports 24 wk trial results of a JAK3 inhibitor and TYK2/JAK1 inhibitor in patients with alopecial areata. The 24 wk placebo-adjusted mean improvements were 33.6 and 49.5 points (P<0.0001), evident as early as Week 6, https://t.co/zN2aGpHXWk
7. Maastricht Study Links Dairy Intake to Osteoarthritis   
8. Unproven But Profitable Stem Cell Clinics  
9. An Association between GCA and IBD       
10. Breast Implant Study: More Worries or Not?  
11. New Classification of Idiopathic Inflammatory Myopathies